GGrantIndex
Sort

40,608 grants matching prostate cancer

STUDIES OF FAS INHIBITION IN HUMAN BREAST CANCER CELLS

$294,300
Johns Hopkins University · R01 · FY2001 · CA

STUDIES OF FAS INHIBITION IN HUMAN BREAST CANCER CELLS

$294,300
Johns Hopkins University · R01 · FY2002 · CA

STUDIES OF FAS INHIBITION IN HUMAN BREAST CANCER CELLS

$294,300
Johns Hopkins University · R01 · FY2003 · CA

Differential Mapping of Posttranslational Modifications in Tumor Cells

$294,272
David M. Lubman · University Of Michigan At Ann Arbor · R01 · FY2007 · GM

Loss of Nkx3.1-an Initiating Event in Prostate Cancer

$294,270
Jeffrey D Milbrandt · Washington University · R01 · FY2006 · CA

Fish Oil Supplement Prevention of Prostate Cancer

$294,261
Wake Forest University Health Sciences · R01 · FY2004 · CA

Mitochondrial DNA in Mutations in Prostate Cancer

$294,240
Emory University · R01 · FY2002 · CA

Role of Raf Kinase Inhibitory Protein in Prostate Cancer

$294,237
Marsha R Rosner · University Of Chicago · R01 · FY2007 · CA

Targeting Malignant Stem Cells in CLL

$294,221
Margaret Goodell · Baylor College Of Medicine · P50 · FY2009 · CA

The mechanism of angiogenin-induced angiogenesis

$294,206
Guo-Fu Hu · Harvard Medical School · R01 · FY2006 · CA

Mechanisms of Fish Oil Supplement in Prevention of Pros*

$294,175
Wake Forest University Health Sciences · R01 · FY2005 · CA

Targeting Leukemia Stem Cells with Dietary Selenium

$294,125
Kumble Sandeep Prabhu · Pennsylvania State University, The · R01 · FY2014 · CA

The Clinical and Epidemiological Characterization of Pathogenic DNA Damage Repair Pathway Variation in Prostate Cancer

$294,110
Kenneth Offit · Sloan-Kettering Inst Can Research · P01 · FY2023 · CA

The Clinical and Epidemiological Characterization of Pathogenic DNA Damage Repair Pathway Variation in Prostate Cancer

$294,110
Kenneth Offit · Sloan-Kettering Inst Can Research · P01 · FY2022 · CA

Molecular Regulation of Androgen Receptor Activation

$294,105
Brigham And Women'S Hospital · R01 · FY2002 · CA

Microenvironmental Nutrient Availability and Immunomodulation in Lung Cancer Cells: A systems biochemical approach

$294,066
Teresa W-M Fan · University Of Kentucky · P01 · FY2016 · CA

Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced Cancers

$294,028
Niall John Lennon · Broad Institute, Inc. · UH3 · FY2022 · CA

ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE

$294,000
Northwestern University · R01 · FY2005 · DK

Neuropeptide Signaling in Prostate Cancer

$294,000
Weill Medical College Of Cornell Univ · R01 · FY2004 · DK

ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE

$294,000
Northwestern University · R01 · FY2003 · DK

Neuropeptide Signaling in Prostate Cancer

$294,000
Weill Medical College Of Cornell Univ · R01 · FY2003 · DK

Neuropeptide Signaling in Prostate Cancer

$294,000
Weill Medical College Of Cornell Univ · R01 · FY2005 · DK

ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE

$294,000
Northwestern University · R01 · FY2004 · DK

ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE

$294,000
Northwestern University · R01 · FY2002 · DK

Effect of Omega-3 Fatty Acids on Cancer Stem Cells

$293,956
Kumble Sandeep Prabhu · Pennsylvania State University, The · R01 · FY2014 · CA